Proof of concept STEP-52 trial shows treatment efficacy and stability of PTSD symptoms when moving from unregulated drug to APEX-52 GMP drug product. VANCOUVER, BC, March 29, 2023 /PRNewswire/ – Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.